NEW! Investment Companies Centre

Medicsight (MDST)

Sector:

Software & Computer Services

Index:

FTSE AIM 50

Market Cap

£40.44m

Change Today

Price Down-0.50p ()

Share Price

26.00p

London afternoon: Commodities, Fannie Mae hurt Footsie

Date: Friday 08 Aug 2008

  • Market Movers
  • FTSE 100 5,430.90 -0.85%
  • techMARK 1,396.22 +0.46%
  • FTSE 250 9,113.70 +0.28%

LONDON (ShareCast) - Resource stocks are leading London's blue chips lower, while disappointing second-quarter results from Fannie Mae are putting pressure on the financial sector.

Kazakhmys, Antofagasta, Xstrata, Vedanta Resources and BHP Billiton are among the heaviest fallers in the mining sector, tracking copper prices lower.

The drop in crude sends the likes of BP and Shell slightly lower, but BG Group is on the rise after the oil and gas giant reported a ‘material’ new oil discovery in the pre-salt Santos Basin, offshore Brazil. The exploration well, known as Iara, discovered 30 degrees API light crude oil within the BM-S-11 concession area.

British Airways and cruise operator Carnival are given a boost by the lower oil price.

Royal Bank of Scotland is doing well as the group’s £691m half-year loss, on a pro-forma basis, was not as steep as first feared .“It has been a chastening experience and reporting a pre-tax loss of £691 million is something I and my colleagues regret very much,” said chief executive Fred Goodwin. Writedowns for the half-year was £5.9bn.

British American Tobacco is another big fallers after the group said it is seeking approval from the Johannesburg Stock Exchange to obtain a secondary listing there to help Richemont and Remgro restructure their stakes in the company.

Pre-tax profit fell 27% at fund manager Schroders in the first half, reflecting lower realizations from its Private Equity business and unrealised fair value write downs on investments in the first quarter. Group profit dropped to £135.7m from £185.6m in 2007 as profit at Private Equity slumped to £7.4m from £36.2m, although it rose 14% at Asset Management and Private Banking.

Goldman Sachs has lowered its rating on Vodafone to ‘neutral’ from ‘buy’ following a recent recovery in the mobile phone giant’s value.

Northern Foods is undervalued despite the prospect of continued weak consumer spending in the UK, Goldman Sachs said as it raised its rating on the Goodfella’s pizza maker to ‘buy’ from ‘neutral’.

Concerns over Kesa Electicals’ exposure to weak consumer spending in the UK prompted Deutsche Bank to lower its rating on the Comet owner to ‘hold’ from ‘buy’.

Insurer and underwriter Catlin reported a 21% slide in first half pre-tax profit to $150m but said it is on track to achieve good results for the full year. “We are confident about the group's prospects,” said chief executive Stephen Catlin.

Agricultural, food and engineering group Carr’s Milling expects pre-tax profit for the year to “substantially” exceed expectations.

Stanley Gibbons benefited from weaker financial markets during the first half as investors snapped up stamps and other collectibles.

Computer aided detection (CAD) and image analysis software company Medicsight said it continues to make progress in line with expectations as losses increased for the half year.

Crockery and pottery firm Portmeirion reported lower first half pre-tax profits and said its full-year performance might be below expectations.

Avon Rubber lost grip as problems producing filters for the US government will increase costs, while delays in getting another contract will also reduce revenues this year.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Medicsight Market Data

Currency UK Pounds
Share Price 26.00p Price Down
Change Today -0.50p
52 Week High 110.25
52 Week Low 23.00
Volume 0
Shares Issued 155.52m
Market Cap £40.44m
Beta 0.28
RiskGrade 443

Performance Indicators

Compare performance with the sector and the market.
Find out more
Key: vs Market vs Sector
Value
32.41% below the market average32.41% below the market average32.41% below the market average32.41% below the market average32.41% below the market average
15.11% below the sector average15.11% below the sector average15.11% below the sector average15.11% below the sector average15.11% below the sector average
Price Trend
8.13% below the market average8.13% below the market average8.13% below the market average8.13% below the market average8.13% below the market average
24.32% below the sector average24.32% below the sector average24.32% below the sector average24.32% below the sector average24.32% below the sector average
Income Not Available
Growth Not Available
Price Chg 6m
45.23% below the market average45.23% below the market average45.23% below the market average45.23% below the market average45.23% below the market average
59.46% below the sector average59.46% below the sector average59.46% below the sector average59.46% below the sector average59.46% below the sector average
P/E Not Available
PEG Not Available
Dividend Yield Not Available
EPS Growth Not Available
Operating Margin
99.54% below the market average99.54% below the market average99.54% below the market average99.54% below the market average99.54% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

What The Brokers Say

Strong Buy 0
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 1
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Medicsight Dividends

No dividends found

Trades for --2008

Time Volume / Share Price
0 @ 0.000p

Medicsight Key Personnel

CEO David Sumner
Chair Timothy Paterson-Brown
CFO Allan Rowley

Digital Look have been voted
"Best Research and Information Provider"

4th Floor, Bankside House, 107 Leadenhall Street, London EC3A 4AF.
Registered in England and Wales (registered no. 3678570).